129 related articles for article (PubMed ID: 7674131)
21. Bile salt-fatty acid mixed micelles as nasal absorption promoters. III. Effects on nasal transport and enzymatic degradation of acyclovir prodrugs.
Shao Z; Mitra AK
Pharm Res; 1994 Feb; 11(2):243-50. PubMed ID: 8165183
[TBL] [Abstract][Full Text] [Related]
22. Effects of various absorption enhancers on the intestinal absorption of water soluble drugs by in vitro Ussing chamber method: correlation with an in situ absorption experiment.
Sugiyama T; Yamamoto A; Kawabe Y; Uchiyama T; Quan YS; Muranishi S
Biol Pharm Bull; 1997 Jul; 20(7):812-4. PubMed ID: 9255426
[TBL] [Abstract][Full Text] [Related]
23. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.
Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A
J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081
[TBL] [Abstract][Full Text] [Related]
24. Intestinal absorption of drugs. III. The influence of taurocholate on the disappearance kinetics of hydrophilic and lipophilic drugs from the small intestine of the rat.
Poelma FG; Breäs R; Tukker JJ
Pharm Res; 1990 Apr; 7(4):392-7. PubMed ID: 2362914
[TBL] [Abstract][Full Text] [Related]
25. Complexation of tanshinone IIA with 2-hydroxypropyl-beta-cyclodextrin: effect on aqueous solubility, dissolution rate, and intestinal absorption behavior in rats.
Wang L; Jiang X; Xu W; Li C
Int J Pharm; 2007 Aug; 341(1-2):58-67. PubMed ID: 17482783
[TBL] [Abstract][Full Text] [Related]
26. Reversal of bropirimine developmental toxicity with progesterone.
Black DL; Marks TA; Branstetter DG; Kirton KT
Toxicol Appl Pharmacol; 1991 Mar; 108(1):121-8. PubMed ID: 2006500
[TBL] [Abstract][Full Text] [Related]
27. Variability in the developmental toxicity of bropirimine with the day of administration.
Marks TA; Black DL; Terry RD; Branstetter DG; Kirton KT
Teratology; 1990 Jul; 42(1):55-66. PubMed ID: 2392779
[TBL] [Abstract][Full Text] [Related]
28. Fat absorption after infusing bile salts into the human small intestine.
Shimoda SS; O'Brien TK; Saunders DR
Gastroenterology; 1974 Jul; 67(1):7-18. PubMed ID: 4366283
[No Abstract] [Full Text] [Related]
29. Oral bropirimine immunotherapy of rodent prostate cancer.
Sarosdy MF
Eur Urol; 1997; 31 Suppl 1():5-9. PubMed ID: 9076480
[TBL] [Abstract][Full Text] [Related]
30. In situ intestinal absorption of a poorly water-soluble drug from mixed micellar solutions of bile salt and lipolysis products in rats.
Serajuddin AT; Rosoff M; Goldberg AH
Pharm Res; 1985 Sep; 2(5):221-4. PubMed ID: 24272840
[TBL] [Abstract][Full Text] [Related]
31. Quantitative estimation of the effects of bile salt surfactant systems on insulin stability and permeability in the rat intestine using a mass balance model.
Lane ME; O'driscoll CM; Corrigan OI
J Pharm Pharmacol; 2005 Feb; 57(2):169-75. PubMed ID: 15720779
[TBL] [Abstract][Full Text] [Related]
32. Effects of different absorption enhancers on the permeation of ebiratide, an ACTH analogue, across intestinal membranes.
Yamamoto A; Okagawa T; Kotani A; Uchiyama T; Shimura T; Tabata S; Kondo S; Muranishi S
J Pharm Pharmacol; 1997 Nov; 49(11):1057-61. PubMed ID: 9401937
[TBL] [Abstract][Full Text] [Related]
33. Structural studies on bioactive compounds. Part 26. Hydrogen bonding in the crystal structure of the N-methylformamide solvate of the immunomodulatory agent 2-amino-5-bromo-6-phenylpyrimidin-4-one (bropirimine): implications for the design of novel anti-tumour strategies.
Stevens MF; Schwalbe CH; Patel N; Gate EN; Bryant PK
Anticancer Drug Des; 1995 Apr; 10(3):203-13. PubMed ID: 7748455
[TBL] [Abstract][Full Text] [Related]
34. Bile salt and non-bile salt components in bile affecting micellar cholesterol uptake by rat intestine in vitro.
Rampone AJ
J Physiol; 1972 Dec; 227(3):889-98. PubMed ID: 4650941
[TBL] [Abstract][Full Text] [Related]
35. Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3.
Fuchs A; Leigh M; Kloefer B; Dressman JB
Eur J Pharm Biopharm; 2015 Aug; 94():229-40. PubMed ID: 26032292
[TBL] [Abstract][Full Text] [Related]
36. Acyclovir permeation enhancement across intestinal and nasal mucosae by bile salt-acylcarnitine mixed micelles.
Park GB; Shao Z; Mitra AK
Pharm Res; 1992 Oct; 9(10):1262-7. PubMed ID: 1448423
[TBL] [Abstract][Full Text] [Related]
37. In vitro-in vivo correlation of the effect of supersaturation on the intestinal absorption of BCS Class 2 drugs.
Higashino H; Hasegawa T; Yamamoto M; Matsui R; Masaoka Y; Kataoka M; Sakuma S; Yamashita S
Mol Pharm; 2014 Mar; 11(3):746-54. PubMed ID: 24460473
[TBL] [Abstract][Full Text] [Related]
38. The effects of cyclic imides on lipid absorption from the intestine and on bile lipids and bile acids of Sprague Dawley rats.
Hall IH; Reynolds DJ; Wong OT; Simlot S
Pharmacol Res; 1993; 27(2):129-39. PubMed ID: 8474958
[TBL] [Abstract][Full Text] [Related]
39. [Glucose transport across the mucosa of the small intestine].
Kosarev AV
Vopr Pitan; 1976; (4):29-9. PubMed ID: 15346
[TBL] [Abstract][Full Text] [Related]
40. Enhanced small intestinal absorption of beta-lactam antibiotics in rats in the presence of monodesmosides isolated from pericarps of Sapindus mukurossi (Enmei-hi).
Yata N; Sugihara N; Yamajo R; Murakami T; Higashi Y; Kimata H; Nakayama K; Kuzuki T; Tanaka O
J Pharmacobiodyn; 1986 Feb; 9(2):211-7. PubMed ID: 3712217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
